Amalgamated Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Sell
263,122
-12,254
-4% -$665K 0.08% 209
2026
Q1
$17.3M Sell
275,376
-5,330
-2% -$426K 0.13% 118
2025
Q4
$26.8M Sell
280,706
-17,045
-6% -$1.67M 0.19% 79
2025
Q3
$29.1M Sell
297,751
-3,248
-1% -$336K 0.21% 78
2025
Q2
$32.3M Buy
300,999
+8,559
+3% +$866K 0.25% 61
2025
Q1
$29.5M Buy
292,440
+2,906
+1% +$293K 0.25% 62
2024
Q4
$25.9M Sell
289,534
-6,770
-2% -$596K 0.21% 75
2024
Q3
$24.8M Sell
296,304
-446
-0.2% -$35.2K 0.2% 76
2024
Q2
$22.9M Sell
296,750
-6,430
-2% -$471K 0.19% 82
2024
Q1
$20.8M Sell
303,180
-53,741
-15% -$3.46M 0.18% 96
2023
Q4
$20.6M Sell
356,921
-18,476
-5% -$986K 0.16% 104
2023
Q3
$19.8M Buy
375,397
+4,485
+1% +$235K 0.17% 102
2023
Q2
$20.1M Sell
370,912
-5,027
-1% -$263K 0.16% 103
2023
Q1
$18.8M Buy
375,939
+2,191
+0.6% +$103K 0.16% 105
2022
Q4
$17.3M Buy
373,748
+4,065
+1% +$176K 0.15% 112
2022
Q3
$14.3M Buy
369,683
+5,198
+1% +$209K 0.14% 122
2022
Q2
$13.6M Buy
364,485
+6,759
+2% +$275K 0.13% 136
2022
Q1
$15.8M Sell
357,726
-25,479
-7% -$1.1M 0.12% 135
2021
Q4
$16.3M Sell
383,205
-1,910
-0.5% -$80.3K 0.12% 133
2021
Q3
$16.7M Sell
385,115
-12,980
-3% -$574K 0.14% 116
2021
Q2
$17M Buy
398,095
+320,078
+410% +$13.5M 0.14% 122
2021
Q1
$3.02M Sell
78,017
-3,009
-4% -$114K 0.11% 142
2020
Q4
$2.91M Sell
81,026
-173
-0.2% -$6.24K 0.11% 148
2020
Q3
$3.1M Sell
81,199
-233
-0.3% -$8.98K 0.13% 124
2020
Q2
$2.86M Sell
81,432
-150,586
-65% -$5.42M 0.13% 127
2020
Q1
$7.57M Sell
232,018
-7,610
-3% -$297K 0.19% 105
2019
Q4
$10.8M Buy
239,628
+8,769
+4% +$367K 0.2% 93
2019
Q3
$9.39M Buy
230,859
+46,625
+25% +$1.98M 0.2% 94
2019
Q2
$7.92M Sell
184,234
-15,570
-8% -$599K 0.18% 100
2019
Q1
$7.67M Buy
199,804
+4,525
+2% +$173K 0.19% 102
2018
Q4
$6.9M Sell
195,279
-5,027
-3% -$182K 0.2% 95
2018
Q3
$7.71M Sell
200,306
-6,008
-3% -$210K 0.19% 103
2018
Q2
$6.75M Buy
206,314
+5,753
+3% +$174K 0.16% 115
2018
Q1
$5.48M Buy
200,561
+19,666
+11% +$534K 0.15% 133
2017
Q4
$4.48M Buy
180,895
+15,855
+10% +$437K 0.12% 162
2017
Q3
$4.81M Buy
165,040
+3,580
+2% +$98.9K 0.15% 129
2017
Q2
$4.48M Buy
161,460
+59,126
+58% +$1.57M 0.15% 132
2017
Q1
$2.54M Sell
102,334
-43,914
-30% -$1.07M 0.13% 142
2016
Q4
$3.16M Buy
146,248
+25,449
+21% +$555K 0.14% 130
2016
Q3
$2.88M Buy
120,799
+356
+0.3% +$8.49K 0.17% 103
2016
Q2
$2.87M Buy
120,443
+72,027
+149% +$1.56M 0.17% 102
2016
Q1
$911K Buy
48,416
+12,763
+36% +$224K 0.09% 235
2015
Q4
$657K Sell
35,653
-11,345
-24% -$203K 0.08% 305
2015
Q3
$771K Buy
46,998
+1,375
+3% +$23.5K 0.08% 277
2015
Q2
$808K Buy
45,623
+3,078
+7% +$55K 0.08% 283
2015
Q1
$755K Buy
42,545
+10,737
+34% +$170K 0.09% 264
2014
Q4
$421K Sell
31,808
-5,178
-14% -$66.2K 0.07% 410
2014
Q3
$437K Buy
36,986
+468
+1% +$5.89K 0.07% 401
2014
Q2
$466K Buy
36,518
+3,749
+11% +$48.7K 0.07% 372
2014
Q1
$443K Sell
32,769
-643
-2% -$8.44K 0.08% 372
2013
Q4
$402K Sell
33,412
-354
-1% -$4.18K 0.07% 411
2013
Q3
$396K Sell
33,766
-799
-2% -$8.64K 0.13% 184
2013
Q2
$320K Buy
+34,565
New +$293K 0.12% 166

Other funds holding BSX

Amalgamated Bank's BSX Position: Q2 2026 in Review

Amalgamated Bank reduced its Boston Scientific (BSX) stake by 4.4% in Q2 2026, selling an estimated $665K and leaving 263,122 shares worth $11.2M. The position accounts for 0.08% of the portfolio, ranked #209.

Amalgamated Bank first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $32.3M in Q2 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Amalgamated Bank held 263,122 shares of Boston Scientific worth $11.2M as of Q2 2026.
  • Amalgamated Bank sold 12,254 Boston Scientific shares in Q2 2026, an estimated $665K.
  • Boston Scientific made up 0.08% of Amalgamated Bank's portfolio in Q2 2026, its #209 holding.
  • Amalgamated Bank first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • Amalgamated Bank's Boston Scientific position peaked at $32.3M in Q2 2025.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.